XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Other Comprehensive Income
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at the beginning of the period at Dec. 31, 2021 $ 507 $ (56,800) $ 1,116,921 $ 12,540 $ (681,283) $ 1,483 $ (44,260) $ 437,628
Balance at the beginning of the period (in shares) at Dec. 31, 2021 50,653              
Balance at the end of the period (in shares) at Dec. 31, 2022 51,660              
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         166,942     166,942
Other comprehensive income (loss), net of tax           (555)   (555)
Share-based compensation expense     22,994         22,994
Net issuance under employee stock plans $ 10   (4,935)         (4,925)
Net issuance under employee stock plans (in shares) 1,007              
Balance at the end of the period at Dec. 31, 2022 $ 517   1,078,180   (501,801) 928   577,824
Balance at the beginning of the period (in shares) at Dec. 31, 2021 50,653              
Balance at the end of the period (in shares) at Dec. 31, 2022 51,660              
Balance at the end of the period (in shares) at Dec. 31, 2023 56,364              
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         (30,368)     (30,368)
Other comprehensive income (loss), net of tax           679   679
Share-based compensation expense     28,558         28,558
Net issuance under employee stock plans $ 2   (6,393)         (6,391)
Net issuance under employee stock plans (in shares) 244              
Partial extinguishment of 2025 and 2027 Notes $ 45   102,095         102,140
Partial extinguishment of 2025 and 2027 Notes (in shares) 4,460              
Balance at the end of the period at Dec. 31, 2023 $ 564   1,202,440   (532,169) 1,607   672,442
Balance at the beginning of the period (in shares) at Dec. 31, 2022 51,660              
Balance at the end of the period (in shares) at Dec. 31, 2023 56,364              
Balance at the end of the period (in shares) at Dec. 31, 2024 56,828              
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         73,714     73,714
Other comprehensive income (loss), net of tax           (85)   (85)
Share-based compensation expense     35,879         35,879
Net issuance under employee stock plans $ 5   (11,185)         (11,180)
Net issuance under employee stock plans (in shares) 464              
Balance at the end of the period at Dec. 31, 2024 $ 569   $ 1,227,134   $ (458,455) $ 1,522   $ 770,770
Balance at the beginning of the period (in shares) at Dec. 31, 2023 56,364              
Balance at the end of the period (in shares) at Dec. 31, 2024 56,828